Sleep Medicine
Volume 1, Issue 3 , Pages 231-243, 1 July 2000

Long-term efficacy and safety of modafinil (PROVIGIL®) for the treatment of excessive daytime sleepiness associated with narcolepsy

  • Merrill M Mitler

      Affiliations

    • Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA, USA
    • Corresponding Author InformationCorresponding author. Sleep Disorders Center, Scripps Clinic Research Foundation, 9834 Genesee Avenue, Suite 328, La Jolla, CA 92037, USA. Tel.: +1-619-784-9295; fax: +1-619-657-0559
    • ,
  • John Harsh

      Affiliations

    • Sleep Disorders Center, Forrest General Hospital, Hattiesburg, MI, USA
    • ,
  • Max Hirshkowitz

      Affiliations

    • Sleep Diagnostic Center, VA Medical Center, Houston, TX, USA
    • ,
  • Christian Guilleminault

      Affiliations

    • Stanford Sleep Disorders Clinic, Stanford, CA, USA
    • ,
  • for the U.S. Modafinil in Narcolepsy Multicenter Study Group

Received 23 February 2000; received in revised form 27 March 2000; accepted 28 March 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1389-9457(00)00031-9

Sleep Medicine
Volume 1, Issue 3 , Pages 231-243, 1 July 2000

Article Tools

* Image Usage & Resolution